Last reviewed · How we verify

QIVc — Competitive Intelligence Brief

QIVc (QIVc) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated influenza vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

QIVc (QIVc) — Seqirus. QIVc is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
QIVc TARGET QIVc Seqirus phase 3 Inactivated influenza vaccine
Fluarix Tetra Vaccine Fluarix Tetra Vaccine GlaxoSmithKline marketed Inactivated influenza vaccine
High-Dose Influenza Vaccine High-Dose Influenza Vaccine Saad Jamshed MD marketed Inactivated influenza vaccine
High Dose Trivalent Influenza Vaccine High Dose Trivalent Influenza Vaccine Brigham and Women's Hospital marketed Inactivated influenza vaccine
Prepandrix™ Prepandrix™ GlaxoSmithKline marketed Inactivated influenza vaccine H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase)
SP Shz TIV SP Shz TIV Sanofi marketed Inactivated influenza vaccine
Anti-H1N1v Vaccine Anti-H1N1v Vaccine Institut National de la Santé Et de la Recherche Médicale, France marketed Inactivated influenza vaccine H1N1 influenza virus hemagglutinin and neuraminidase antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Seqirus · 5 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
  4. Green Cross Corporation · 4 drugs in this class
  5. Novartis · 2 drugs in this class
  6. SK Chemicals Co., Ltd. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Hospital Israelita Albert Einstein · 2 drugs in this class
  9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
  10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). QIVc — Competitive Intelligence Brief. https://druglandscape.com/ci/qivc. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: